- Oops!Something went wrong.Please try again later.
DGAP-News: CytoTools AG / Key word(s): Personnel
Supervisory Board of CytoTools AG announces the retirement of the two members of the Management Board according to schedule
Darmstadt, 30 September 2021 - The Supervisory Board of CytoTools AG (ISIN DE000A0KFRJ1) announces that the appointment of the two members of the Management Board of CytoTools AG, Dr. Mark-Andre Freyberg and Dr. Dirk Kaiser, will end by rotation on 30 September 2021. Following today's deselection by the Supervisory Board, both members of the Management Board are not available for a contract extension. Both members of the Management Board have therefore left the Company's Management Board today.
The Supervisory Board very much regrets that Dr. Freyberg and Dr. Kaiser are not available for a further term of office due to the current situation and expresses its respect and high appreciation for their successful work over the past 15 years. Dr. Freyberg and Dr. Kaiser will remain closely associated with the Company as founders and shareholders.
This release contains certain forward-looking statements. These reflect the views of CytoTools as of the date of this release. Actual results achieved by CytoTools may differ materially from the findings in the forward-looking statements. CytoTools is under no obligation to update any forward-looking statements.
30.09.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
Klappacher Str. 126
+49 (0)6151-951 58 12
+49 (0)6151-951 58 13
Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Hamburg, Stuttgart, Tradegate Exchange
EQS News ID:
End of News
DGAP News Service